Cargando…
Combining phenotypic and proteomic approaches to identify membrane targets in a ‘triple negative’ breast cancer cell type
BACKGROUND: The continued discovery of therapeutic antibodies, which address unmet medical needs, requires the continued discovery of tractable antibody targets. Multiple protein-level target discovery approaches are available and these can be used in combination to extensively survey relevant cell...
Autores principales: | Rust, Steven, Guillard, Sandrine, Sachsenmeier, Kris, Hay, Carl, Davidson, Max, Karlsson, Anders, Karlsson, Roger, Brand, Erin, Lowne, David, Elvin, John, Flynn, Matt, Kurosawa, Gene, Hollingsworth, Robert, Jermutus, Lutz, Minter, Ralph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582597/ https://www.ncbi.nlm.nih.gov/pubmed/23406016 http://dx.doi.org/10.1186/1476-4598-12-11 |
Ejemplares similares
-
Identification of anti-tumour biologics using primary tumour models, 3-D phenotypic screening and image-based multi-parametric profiling
por: Sandercock, Alan M., et al.
Publicado: (2015) -
Improved drug-like properties of therapeutic proteins by directed evolution
por: Buchanan, Andrew, et al.
Publicado: (2012) -
Tailored amino acid diversity for the evolution of antibody affinity
por: González-Muñoz, Andrea, et al.
Publicado: (2012) -
We need to bring R0 < 1 to treat cancer too
por: Srikrishna, Devabhaktuni, et al.
Publicado: (2021) -
Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapy
por: Williams, Geoffrey S., et al.
Publicado: (2016)